Seeing Is Believing
Spark Therapeutics's activity chart (see below) currently has 127 price targets and 96 ratings on display.
Analysts average stock forecasts to be materialized ratio is 95.78% with an average time for these price targets to be met of 182.09 days.
Most recent stock forecast was given by PHIL NADEAU from TD COWEN on 25-Mar-2019. First documented stock forecast 24-Feb-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Feb-2015
$80
7 years 7 months 7 days ago
(25-Mar-2019)
7/7 (100%)
$23.99 (42.83%)
386
Buy Since 25-Mar-2019
$115
$1.43 (1.26%)
7 years 7 months 7 days ago
(25-Mar-2019)
7/8 (87.5%)
$1.47 (1.29%)
248
Buy Since 02-Aug-2017
$65
$-48.57 (-42.77%)
$65
7 years 8 months 5 days ago
(27-Feb-2019)
8/9 (88.89%)
$-48.4 (-42.68%)
179
$114.5
$0.93 (0.82%)
$48
7 years 8 months 6 days ago
(26-Feb-2019)
12/13 (92.31%)
$1.05 (0.93%)
122
Buy Since 12-Jul-2016
$72
7 years 8 months 6 days ago
(26-Feb-2019)
6/6 (100%)
$16.24 (29.12%)
280
What is ONCE (Spark Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on ONCE (Spark Therapeutics)?
Which analyst has the most public recommendations on ONCE (Spark Therapeutics)?
Which analyst is the currently most bullish on ONCE (Spark Therapeutics)?
Which analyst is the currently most reserved on ONCE (Spark Therapeutics)?